Publication | Closed Access

A novel synthetic derivative of melatonin, 5-hydroxy-2’-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation

InflammationAnti-inflammatoryOxysterolBiochemistryInflammasome ActivationMedicineTrif-dependent SignalingNovel Synthetic DerivativePharmacological AgentPharmacologyCell BiologyCell SignalingMelatoninOxidative Stress